vTv Therapeutics Inc. Contracts & Agreements
77 Contracts & Agreements
- Business Finance (25 contracts)
- Business Formation (2)
- Business Operations (2)
- Human Resources (16)
- Intellectual Property (10)
- Mergers & Acquisitions (2)
- Uncategorized (20)
- Deed of Novation, dated as of December 21, 2022, by and between vTv Therapeutics LLC, G42 Healthcare Technology Projects LLC and G42 Healthcare Technology Solutions LLC (f/k/a... (Filed With SEC on March 6, 2023)
- Deed of Variation, dated as of February 28, 2023, by and between vTv Therapeutics Inc., G42 Investments AI Holding RSC Ltd., and Group 42 Holding Limited (Filed With SEC on March 6, 2023)
- Tuch Employment Agreement (Filed With SEC on December 13, 2022)
- Sekhri Employment Agreement (Filed With SEC on July 27, 2022)
- Inducement Award Agreement (Filed With SEC on July 27, 2022)
- Warrant to Purchase Shares of Common Stock (Filed With SEC on July 25, 2022)
- Common Stock and Warrant Purchase Agreement, dated as of July 22, 2022, by and among vTv Therapeutics Inc., CinPax, LLC and CinRx Pharma, LLC (Filed With SEC on July 25, 2022)
- Common Stock Purchase Agreement, dated as of May 31, 2022, by and among vTv Therapeutics Inc., G42 Investments AI Holding RSC Ltd. and, solely for Sections 5.3, 5.11 and Section 6... (Filed With SEC on June 1, 2022)
- Deepa Prasad Separation Agreement (Filed With SEC on May 12, 2022)
- Richard S. Nelson Employment Agreement (Filed With SEC on May 12, 2022)
- Description of Capital Stock (Filed With SEC on March 29, 2022)
- Howard Resignation Agreement (Filed With SEC on December 2, 2021)
- Retirement Agreement (Filed With SEC on October 20, 2021)
- Prasad Employment Agreement (Filed With SEC on October 20, 2021)
- Inducement Award Agreement (Filed With SEC on October 20, 2021)
- Description of Capital Stock (Filed With SEC on February 24, 2021)
- License Agreement, dated December 11, 2020, by and between Anteris Bio, Inc. and vTv Therapeutics LLC (Filed With SEC on February 24, 2021)
- First Amendment to License Agreement, dated as of December 21, 2020 by and between Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. And vTv Therapeutics LLC (Filed With SEC on February 24, 2021)
- Executive Chairman Agreement, dated as of December 30, 2020, by and between vTv Therapeutics Inc. and Robin E. Abrams (Filed With SEC on December 30, 2020)
- Employment Agreement, dated as of December 10, 2020, by and between vTv Therapeutics LLC and Stephen L. Holcombe, and for certain limited purposes specified therein, vTv... (Filed With SEC on December 10, 2020)
- Employment Agreement, dated as of December 10, 2020, by and between vTv Therapeutics LLC and Rudy C. Howard, and for certain limited purposes specified therein, vTv Therapeutics... (Filed With SEC on December 10, 2020)
- Purchase Agreement, dated November 24, 2020, by and between vTv Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on November 24, 2020)
- Registration Rights Agreement, dated November 24, 2020, by and between vTv Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on November 24, 2020)
- Third Amendment of Venture Loan and Security Agreement and Consent, dated as of July 29, 2020, by and among the Company, vTv Therapeutics LLC, Horizon Funding Trust 2019-1 and... (Filed With SEC on August 3, 2020)
- Second Amendment of Venture Loan and Security Agreement and Consent, dated as of April 1, 2020, by and among the Company, vTv Therapeutics LLC, Horizon Funding Trust 2019-1 and... (Filed With SEC on May 7, 2020)
- Controlled Equity OfferingSM Sales Agreement, dated as of April 24, 2020, by and between vTv Therapeutics Inc. and Cantor Fitzgerald & Co (Filed With SEC on April 24, 2020)
- Description of Capital Stock (Filed With SEC on February 21, 2020)
- Letter Agreement, dated as of December 23, 2019, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on February 21, 2020)
- Form of Securities Purchase Agreement to Purchase Class A Common Stock, under the December 23, 2019 Letter Agreement, by and between MacAndrews & Forbes Group LLC and vTv... (Filed With SEC on February 21, 2020)
- Letter Agreement, dated as of September 26, 2019, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on October 30, 2019)
- Form of Securities Purchase Agreement to Purchase Class A Common Stock, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on October 30, 2019)
- Form of Securities Purchase Agreement, dated as of March 18, 2019 among vTv Therapeutics and the Purchasers (Filed With SEC on March 20, 2019)
- Letter Agreement, dated March 18, 2019, between vTv Therapeutics Inc. and MacAndrews & Forbes Group, LLC (Filed With SEC on March 20, 2019)
- Employment Agreement, dated as of March 7, 2019, by and between vTv Therapeutics LLC and Stephen L. Holcombe, and for certain limited purposes specified therein, vTv Therapeutics... (Filed With SEC on March 11, 2019)
- Employment Agreement, dated as of March 7, 2019, by and between vTv Therapeutics LLC and Rudy C. Howard, and for certain limited purposes specified therein, vTv Therapeutics Inc (Filed With SEC on March 11, 2019)
- Letter Agreement, dated as of December 11, 2018, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on February 26, 2019)
- Form of Securities Purchase Agreement to Purchase Class A Common Stock, under the December 11, 2018 Letter Agreement, by and between MacAndrews & Forbes Group LLC and vTv... (Filed With SEC on February 26, 2019)
- Letter Agreement, dated as of July 30, 2018, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on November 8, 2018)
- Form of Securities Purchase Agreement to Purchase Class A Common Stock, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on November 8, 2018)
- License Agreement, dated as of May 31, 2018, by and between Newsoara Biopharma Co., Ltd. and vTv Therapeutics LLC (Filed With SEC on August 3, 2018)
- Form of Securities Purchase Agreement to Purchase Class A Common Stock, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics LLC (Filed With SEC on August 3, 2018)
- Common Stock Purchase Warrant (Filed With SEC on February 27, 2018)
- First Amendment of Venture Loan and Security Agreement and Consent, dated as of December 20, 2017, by and among the Company, vTv Therapeutics LLC, Horizon Credit II LLC and... (Filed With SEC on February 27, 2018)
- Letter Agreement, dated as of December 5, 2017, by and between MacAndrews & Forbes Group LLC and vTv Therapeutics Inc (Filed With SEC on February 27, 2018)
- License and Research Agreement, dated as of December 21, 2017, by and between Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. And vTv Therapeutics LLC (Filed With SEC on February 27, 2018)
- License and Research Agreement, dated as of December 21, 2017, by and between Reneo Pharmaceuticals, Inc. and vTv Therapeutics LLC (Filed With SEC on February 27, 2018)
- VTV THERAPEUTICS INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on May 3, 2017)
- FORM OF WARRANT TO PURCHASE CLASS A COMMON STOCK (Loan [A/B/C/D/E/F]) (Filed With SEC on February 24, 2017)
- VENTURE LOAN AND SECURITY AGREEMENT (Filed With SEC on February 24, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 4, 2016)
- REORGANIZATION AGREEMENT Dated as of July 29, 2015 (Filed With SEC on August 4, 2015)
- AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of July 29, 2015 (Filed With SEC on August 4, 2015)
- INVESTOR RIGHTS AGREEMENT dated as of July 29, 2015 among VTV THERAPEUTICS INC. and VTV THERAPEUTICS HOLDINGS LLC (Filed With SEC on August 4, 2015)
- EXCHANGE AGREEMENT (Filed With SEC on August 4, 2015)
- TAX RECEIVABLE AGREEMENT among vTv THERAPEUTICS INC., and THE PERSONS NAMED HEREIN Dated as of July 29, 2015 (Filed With SEC on August 4, 2015)
- vTv Therapeutics Inc. 2015 Omnibus EquityIncentive Plan (Filed With SEC on August 4, 2015)
- VTV THERAPEUTICS INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN NONQUALIFIED OPTION AWARD AGREEMENT (Filed With SEC on August 4, 2015)
- [ ]Shares vTv Therapeutics Inc. Class A Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 23, 2015)
- REORGANIZATION AGREEMENT Dated as of [_________] 2015 (Filed With SEC on July 23, 2015)
- INVESTOR RIGHTS AGREEMENT dated as of [_______], 2015 among VTV THERAPEUTICS INC. and VTV THERAPEUTICS HOLDINGS LLC (Filed With SEC on July 23, 2015)
- AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of [__________], 2015 (Filed With SEC on July 23, 2015)
- EXCHANGE AGREEMENT (Filed With SEC on July 23, 2015)
- TAX RECEIVABLE AGREEMENT among vTv THERAPEUTICS INC., and THE PERSONS NAMED HEREIN Dated as of [_________ ___], 2015 (Filed With SEC on July 23, 2015)
- vTv Therapeutics Inc. 4170 Mendenhall Oaks Pkwy High Point, NC 27265 (Filed With SEC on July 23, 2015)
- INDEMNIFICATION AGREEMENT by and between VTV THERAPEUTICS INC. and [ ] as Indemnitee (Filed With SEC on July 23, 2015)
- NEW EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on July 23, 2015)
- LICENSE AND RESEARCH AGREEMENT BY AND BETWEEN CALITHERA BIOSCIENCES INC. AND HIGH POINT PHARMACEUTICALS, LLC TRANSTECH PHARMA LLC DATED AS OF MARCH 5, 2015 (Filed With SEC on July 23, 2015)
- vTv Therapeutics Inc. 2015 Omnibus EquityIncentive Plan (Filed With SEC on July 23, 2015)
- VTV THERAPEUTICS INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN NONQUALIFIED OPTION AWARD AGREEMENT (Filed With SEC on July 23, 2015)
- EXECUTIVE CHAIRMAN AGREEMENT (Filed With SEC on July 20, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on July 20, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on July 20, 2015)
- LICENSE AND RESEARCH AGREEMENT BY AND BETWEEN CALITHERA BIOSCIENCES INC. AND HIGH POINT PHARMACEUTICALS, LLC TRANSTECH PHARMA LLC DATED AS OF MARCH 5, 2015 (Filed With SEC on July 13, 2015)
- AGREEMENT CONCERNING GLUCOKINASE ACTIVATORPROJECT BY AND BETWEEN NOVO NORDISK A/S AND TRANSTECH PHARMA, INC. DATED AS OF FEBRUARY 20, 2007 (Filed With SEC on July 2, 2015)
- NEW EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on July 2, 2015)
- AGREEMENT CONCERNING GLUCOKINASE ACTIVATORPROJECT BY AND BETWEEN NOVO NORDISK A/S AND TRANSTECH PHARMA, INC. DATED AS OF FEBRUARY 20, 2007 (Filed With SEC on June 19, 2015)
- NEW EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on June 19, 2015)
